Is a separate consent form needed for every peptide?

Yes. Every medication has different risks and profiles. A blanket consent form is rarely sufficient for legal protection.

What happens if a patient refuses to sign?

If a patient refuses to sign the informed consent for a compounded medication, you should not proceed with the prescription.

Do these forms need to be updated?

Forms should be updated whenever new safety information becomes available or if the pharmacy source changes.

Compliance

Patient Consent Best Practices for Compounded Medications

Published September 3, 2026 · 4 minutes

Prescribing compounded medications requires specific documentation. Clinical owners must ensure patients understand that compounded drugs are not FDA-approved in the same way as mass-produced pharmaceuticals. This transparency reduces legal risk and builds trust. These best practices help maintain compliance while scaling your weight loss or longevity practice.

Define Compounding for the Patient

Patients often confuse compounding with generic drugs. Your consent form should clearly explain that a compounding pharmacy creates a customized medication. This distinction is vital for regulatory compliance. Use simple language to describe the process.

Explain that the medication is prepared by a licensed pharmacy.
Clarify that the specific formulation is not FDA-approved.
Mention that the facility follows USP standards for safety.
State why a compounded version was chosen for their care plan.

Disclose Safety and Efficacy Data

Your documentation must reflect the current clinical understanding of the prescribed peptides or GLP-1s. Avoid making absolute claims about results. Focus on data-driven expectations and the possibility of side effects.

List common side effects like nausea or injection site reactions.
Note that long-term data for certain new peptides may be limited.
Advise patients on how to report adverse events to your clinic.
Include instructions for proper storage and handling.

Address Off-Label Usage

Many peptides are used off-label in wellness settings. If the medication is being used for a purpose other than its primary indication, the patient must be informed. This is common practice but requires written acknowledgement.

The Verification Process

Consent is not just a signature. It is a conversation. Your staff should verify that the patient has read the documents and had their questions answered. This verbal verification should be noted in the patient's electronic health record.

Use a dedicated witness for the signature when possible.
Provide a copy of the signed document to the patient immediately.
Update consent forms annually or when formulations change.
Ensure the medical director reviews any complex cases.

Maintain Digital Records

Paper files are difficult to track and audit. Use a digital platform to store consent forms. This ensures that every patient has the required paperwork before their first order is processed or shipped.

FAQs

Is a separate consent form needed for every peptide?: Yes. Every medication has different risks and profiles. A blanket consent form is rarely sufficient for legal protection.
What happens if a patient refuses to sign?: If a patient refuses to sign the informed consent for a compounded medication, you should not proceed with the prescription.
Do these forms need to be updated?: Forms should be updated whenever new safety information becomes available or if the pharmacy source changes.

Launch your white-label program

Apply to Direct Peptide Sales, most practices onboard inside 30 days.

Apply now →